ArriVent BioPharma Ownership | Who Owns ArriVent BioPharma?

ArriVent BioPharma Ownership Summary

ArriVent BioPharma is owned by 96.04% institutional investors, 8.24% insiders. Hhlr advisors is the largest institutional shareholder, holding 12.81% of AVBP shares.

AVBP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ArriVent BioPharma	96.04%	8.24%	-4.28%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Hhlr advisors	4.48M	12.81%	$97.63M
Suvretta capital management	3.41M	9.75%	$74.30M
Orbimed advisors	3.03M	8.65%	$65.90M
Novo	1.87M	5.35%	$40.76M
Blackrock funding, inc. /de	1.84M	5.25%	$40.02M
Sofinnova investments	1.70M	4.85%	$36.94M
General catalyst group management	1.49M	4.27%	$32.54M
Siren	700.00K	2.00%	$15.24M
Sc china	663.31K	1.89%	$14.44M
Hidden lake asset management lp	606.85K	1.73%	$13.21M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Hidden lake asset management lp	606.85K	3.60%	$13.21M
Hhlr advisors	4.48M	3.14%	$97.63M
Novo	1.87M	2.88%	$40.76M
Sofinnova investments	1.70M	2.26%	$36.94M
Suvretta capital management	3.41M	2.24%	$74.30M
Orbimed advisors	3.03M	1.65%	$65.90M
Fund 1 investments	528.39K	0.93%	$11.50M
Siren	700.00K	0.79%	$15.24M
General catalyst group management	1.49M	0.76%	$32.54M
Sc china	663.31K	0.74%	$14.44M

Top Buyers

Holder	Shares	% Assets	Change
Suvretta capital management	3.41M	2.24%	1.08M
Siren	700.00K	0.79%	700.00K
Fund 1 investments	528.39K	0.93%	528.39K
Cooperman leon g	421.28K	0.32%	421.28K
Hidden lake asset management lp	606.85K	3.60%	352.48K

Top Sellers

Holder	Shares	% Assets	Change
Octagon capital advisors lp	-	-	-2.06M
Cormorant asset management, lp	-	-	-585.46K
Blackrock funding, inc. /de	1.84M	0.00%	-301.41K
Two sigma investments, lp	-	-	-41.38K
Marshall wace, llp	-	-	-35.85K

New Positions

Holder	Shares	% Assets	Change	Value
Siren	700.00K	0.79%	700.00K	$15.24M
Fund 1 investments	528.39K	0.93%	528.39K	$11.50M
Cooperman leon g	421.28K	0.32%	421.28K	$9.17M
Moody aldrich partners	71.58K	0.30%	71.58K	$1.56M
Verition fund management	56.50K	0.01%	56.50K	$1.23M

Sold Out

Holder	Change
Parallel advisors	-3.00
Advisor group	-17.00
Parkside financial bank & trust	-20.00
Quadrant capital group	-21.00
Ronald blue trust	-39.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	96	15.66%	33,618,963	15.59%	96	1.30%	49	8.89%	30	42.86%
Mar 31, 2025	7	-91.14%	11,264,335	-59.25%	35	0.53%	4	-92.98%	-	-100.00%
Dec 31, 2024	81	20.90%	28,465,927	9.87%	84	1.42%	58	7.41%	11	266.67%
Sep 30, 2024	67	26.42%	25,908,140	19.65%	77	1.85%	54	58.82%	3	-57.14%
Jun 30, 2024	53	-	21,652,506	-0.91%	64	1.52%	34	-35.85%	7	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 30, 2024	HILLHOUSE INVESTMENT MANAGEMENT, LTD.	-	Buy	$10.00M
Jan 30, 2024	ORBIMED ADVISORS LLC		Buy	$4.00M
Jan 30, 2024	GORDON CARL L		Buy	$4.00M
Jan 30, 2024	HEALY JAMES	-	Buy	$8.00M

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2024 Q1	4	-

AVBP Ownership FAQ

Who Owns ArriVent BioPharma?

ArriVent BioPharma shareholders are primarily institutional investors at 96.04%, followed by 8.24% insiders and -4.28% retail investors. The average institutional ownership in ArriVent BioPharma's industry, Biotech Stocks , is 304.14%, which ArriVent BioPharma falls below.

Who owns the most shares of ArriVent BioPharma?

ArriVent BioPharma’s largest shareholders are Hhlr advisors (4.48M shares, 12.81%), Suvretta capital management (3.41M shares, 9.75%), and Orbimed advisors (3.03M shares, 8.65%). Together, they hold 31.21% of ArriVent BioPharma’s total shares outstanding.

Does Blackrock own ArriVent BioPharma?

BlackRock is not among the top 10 institutional shareholders of ArriVent BioPharma.

Who is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested?

Hidden lake asset management lp is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested, with 3.60% of its assets in 606.85K ArriVent BioPharma shares, valued at 13.21M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools